Abstract
Deep brain stimulation of the Anterior Nucleus of the Thalamus (ANT-DBS) is an effective therapy in epilepsy. Poorer surgical outcomes are related to deviations of the lead from the ANT-target. The target identification relies on the visualization of anatomical structures by medical imaging, which presents some disadvantages. This study aims to research whether ANT-LFPs recorded with the Percept (TM) PC neurostimulator can be an asset in the identification of the DBS-target. For this purpose, 17 features were extracted from LFPs recorded from a single patient, who stayed at an Epilepsy Monitoring Unit for a 5-day period. Features were then integrated into two machine learning (ML)-based methodologies, according to different LFP bipolar montages: Pass1 (nonadjacent channels) and Pass2 (adjacent channels). We obtained an accuracy of 76.6% for the Pass1-classifier and 83.33% for the Pass2-classifier in distinguishing locations completely inserted in the target and completely outside. Then, both classifiers were used to predict the target percentage of all combinations, and we found that contacts 3 (left hemisphere) and 2 and 3 (right hemisphere) presented higher signatures of the ANT-target, which agreed with the medical images. This result opens a new window of opportunity for the use of LFPs in the guidance of DBS target identification.

Abstract
The gold standard real-time core temperature (CT) monitoring methods are invasive and cost-inefficient. The application of the Kalman filter for an indirect estimation of CT has been explored in the literature for more than 10 years. This paper presents a comparative study between different state-of-the-art Extended Kalman Filter (EKF) approaches. Moreover, we proposed the addition of an extra layer to the pipeline that applies a pre-emptive mapping concept based on the physiological response of the heart rate (HR) signal, before using it as input to the EKF. The algorithm was trained and tested using two datasets (18 subjects). The best-performing approach with the novel pre-emptive mapping achieved an average Root Mean Squared Error (RMSE) of 0.34 ^?C, while without pre-emptive mapping, it resulted in an RMSE of 0.41 ^?C, leading to a performance improvement of 17%. Given these favorable outcomes, it is compelling to assess the efficacy of this method on a larger dataset in the future.

Abstract

Abstract
Parkinson's Disease (PD) is a neurological disease that progresses over time and causes severe motor symptoms. Therefore, treating PD requires constant patient monitoring, which may turn clinical practice overwhelming, preventing its practical implementation, and raising the need for patient monitoring outside the clinical setting. The iHandU system described in this paper fulfils this need by providing an objective way to quantify motor symptoms of PD in non-clinical settings. It integrates an innovative real-time assessment of the severity of motor symptoms based on signal processing and Machine Learning models that mimic the clinical severity classification scales used in practice and allows for a more continuous and personalized therapy planning and management by doctors, through the use of a web dashboard user-friendly interface. This system, recently tested at 5 patients' homes, has shown promising results as a PD patient management digital platform, reaching a usability score of 83.9% (A grade) based on the System Usability Scale (SUS). Such a level shows a strong alignment between user needs, expectations and functionalities. This study highlights the potential of the used system as a Patient Management Tool showing a case study from an ongoing clinical study. By giving additional information to the doctors with features beyond the semi-quantitative rating scales currently used, allowing a more optimized and continuous PD symptom management, it will be possible to advance PD management further.

Abstract
The progressive and complex nature of Parkinson's disease (PD) may largely benefit from regular and personalised monitoring, which is beyond the current clinical practice and routinely available systems. This paper proposes a simple and effective system to address this issue by using a wearable device to quantify a key PD's motor symptom - gait impairment as a proof-of-concept for a future broader approach. In this study, 60 inertial signals were collected from the ankle in 41 PD patients during a clinical standard gait assessment exercise. Each exercise iteration was classified by a specialised neurologist based on the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS). A signal processing and feature extraction pipeline was employed to characterise gait, followed by a statistical analysis of their ability to differentiate between the 5 levels of impairment. The results revealed that 4 of the 8 studied features exhibited high discriminatory power between different severity levels of gait impairment, with statistical significance. The distinguishing capability of these 4 extracted features - gait consistency, rotation angle, mean height and length of steps - holds great promise for the development of a gait severity quantification remote monitoring for PD patients at home or on the move, proving the concept of the usefulness of wearable devices for regular and personalised PD symptom monitoring.

Abstract
Direct blood pressure (BP) measurements require cuff compression, which not only is time-consuming but also inconvenient for frequent monitoring. This study addresses the challenge of continuous BP estimation (both Systolic (SBP) and Diastolic (DBP)) during exercise in a cuff-less manner, utilizing photoplethysmography (PPG) signals acquired by low-cost wearables. Leveraging Reflective Pulse-wave Transit Time (R-PTT), state-of-the-art algorithms were put to the test in two datasets (total subjects = 18). DATASET1 contains PPG signal and BP measurements of subjects in resting state, while DATASET2 comprises data of subjects in resting state and during exercise. The results reveal competitive performance, with Mean Absolute Error (MAE) of the estimation algorithm for DATASET1 being SBP=7.9 mmHg and DBP=5.2 mmHg and SBP=14.4 mmHg and DBP=7.7 mmHg for DATASET2. DATASET1 consistently outperforms DATASET2, affirming the algorithm's efficacy during resting states and that estimation during physical activity introduces challenges, requiring further refinement and research for real-world applications. In conclusion, this research unveils a viable solution for continuous cuff-less BP monitoring, while emphasizing the need for refinement and validation to enhance its clinical applicability and accessibility.